Insider Transactions in Q3 2020 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2020
|
Richard Bryan Riggsbee Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,653
-2.38%
|
$86,489
$13.04 P/Share
|
|
Sep 30
2020
|
Jerry S Lanchbury Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,544
-2.6%
|
$72,072
$13.04 P/Share
|
|
Sep 30
2020
|
Alexander Ford Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,653
-3.79%
|
$86,489
$13.04 P/Share
|
|
Sep 30
2020
|
Mark Verratti Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
725
-0.65%
|
$9,425
$13.04 P/Share
|
|
Sep 30
2020
|
Nicole Lambert Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
591
-0.94%
|
$7,683
$13.04 P/Share
|
|
Sep 30
2020
|
Benjamin Jackson E.V.P., General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
416
-0.71%
|
$5,408
$13.04 P/Share
|
|
Sep 30
2020
|
Jayne B. Hart Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,218
-4.33%
|
$28,834
$13.04 P/Share
|